Amiodarone-induced organizing pneumonia mimicking COVID-19: a case report
Abstract Background Differential diagnosis of interstitial lung diseases (ILDs) during the COVID-19 pandemic is difficult, due to similarities in clinical and radiological presentation between COVID-19 and other ILDs on the one hand, and frequent false-negative swab results on the other. We describe...
Main Authors: | Gaetano Zizzo, Stefano Caruso, Elisabetta Ricchiuti, Roberto Turato, Ilario Stefani, Antonino Mazzone |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-021-00522-w |
Similar Items
-
Organizing pneumonia secondary to amiodarone treatment
by: João Gomes Carvalho, et al.
Published: (2022-09-01) -
Acute amiodarone pulmonary toxicity in the form of organizing pneumonia triggered by orthotopic heart transplantation
by: Natalya Kozlova, et al.
Published: (2021-01-01) -
Two sides of the coin: Amiodarone-induced lung toxicity – Case Report
by: Klaudiusz Garbacki, et al.
Published: (2022-08-01) -
Early recognition of acute pneumonitis in amiodarone treatment
by: Rishi Vinod Lohiya, et al.
Published: (2018-01-01) -
Amiodarone and its Pulmonal Toxicity
by: Kemalasari Nas Darisan, et al.
Published: (2014-03-01)